
Please try another search
The healthcare industry in developed countries is shifting its focus to other therapy areas and restructuring its operations as COVID-19 infection curves flatten with mass vaccination drives. Given this, we think medical equipment manufacturer Thermo Fisher Scientific (TMO) should witness a substantial rise in its financials and stock price soon. Read on.Thermo Fisher Scientific Inc. (NYSE:TMO) is a leading company in the medical instrument and diagnostic equipment industry, with a market capitalization of $184.71 billion. Shares of TMO have gained 46.1% over the past year, and 5.6% over the past month.
The company’s financials have improved significantly in the last quarter. Its revenues have increased 59% year-over-year to $9.91 billion in the first quarter, ended March 31, and its EPS has risen 198% from the same period last year to $5.88.
Click here to checkout our Healthcare Sector Report for 2021
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.